BIO-TECHNE (TECH) Non-Current Deferred Tax Liability: 2011-2025
Historic Non-Current Deferred Tax Liability for BIO-TECHNE (TECH) over the last 15 years, with Sep 2025 value amounting to $11.3 million.
- BIO-TECHNE's Non-Current Deferred Tax Liability fell 77.46% to $11.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.3 million, marking a year-over-year decrease of 77.46%. This contributed to the annual value of $6.2 million for FY2025, which is 88.96% down from last year.
- As of Q3 2025, BIO-TECHNE's Non-Current Deferred Tax Liability stood at $11.3 million, which was up 82.74% from $6.2 million recorded in Q2 2025.
- In the past 5 years, BIO-TECHNE's Non-Current Deferred Tax Liability ranged from a high of $112.9 million in Q3 2022 and a low of $6.2 million during Q2 2025.
- Over the past 3 years, BIO-TECHNE's median Non-Current Deferred Tax Liability value was $55.9 million (recorded in 2024), while the average stood at $54.1 million.
- Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first climbed by 14.28% in 2022, then plummeted by 88.96% in 2025.
- BIO-TECHNE's Non-Current Deferred Tax Liability (Quarterly) stood at $101.4 million in 2021, then grew by 9.82% to $111.4 million in 2022, then tumbled by 35.74% to $71.6 million in 2023, then tumbled by 47.30% to $37.7 million in 2024, then plummeted by 77.46% to $11.3 million in 2025.
- Its Non-Current Deferred Tax Liability was $11.3 million in Q3 2025, compared to $6.2 million in Q2 2025 and $31.9 million in Q1 2025.